KN-013

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKN-013
Drug Alias Nameanti-RANK-L mAb (Suzhou AlphaMab)KN-013
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSuzhou Alphamab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Alphamab Co Ltd
Active IndicationsN/A
Inactive IndicationsBone metastases

Other Information

ATC CodeN/A
Related LinksN/A